Skip to main content
. 2019 Nov 8;14:192. doi: 10.1186/s13019-019-0999-3

Table 2.

Demographic and Pre/Intra-operative Characteristics (Unmatched)

Variable (mean n, %) All (n = 639) P0 (n = 302) P2(n = 337) p value
Age (years) 66 ± 11.6 67 ± 10.2 65.1 ± 12.6 0.036
Gender (male) 441 (69%) 205 (68%) 236 (70%) 0.61
Weight (kg) 89 ± 20 88 ± 20 90 ± 21 0.13
Diabetes 274 (43%) 118 (39%) 156 (46%) 0.078
Hypertension 515 (81%) 243 (80%) 272 (81%) 1
Prior PCI 155 (24%) 70 (23%) 85 (25%) 0.58
NYHA I 329 (51%) 162 (54%) 167 (50%) 0.3
NYHA II, III or IV 310 (49%) 140 (46%) 170 (50%) 0.3
Preop atrial arrhythmia 131 (21%) 59 (20%) 72 (21%) 0.62
Preop-IABP 50 (7.8%) 25 (8.3%) 25 (7.4%) 0.77
ADP inhibitors 55 (8.6%) 37 (12%) 18 (5.3%) 0.0027
Preop Aspirin 621 (97%) 300 (99%) 321 (95%) 0.0015
Preop Warfarin 6 (0.94%) 3 (0.99%) 3 (0.89%) 1
GIIb/IIIa 7 (1.1%) 7 (2.3%) 0 (0%) 0.0051
First Time Surgery 601 (94%) 284 (94%) 317 (94%) 1
Reoperation 38 (5.9%) 18 (6%) 20 (5.9%) 1
Operative Status (Elective) 269 (42%) 130 (43%) 139 (41%) 0.69
Opertive Status (Non Elective) 370 (58%) 172 (57%) 198 (59%) 0.69
CABG 359 (56%) 167 (55%) 192 (57%) 0.69
Valve 79 (12%) 49 (16%) 30 (8.9%) 0.0056
CABG + Valve 78 (12%) 38 (13%) 40 (12%) 0.81
Other 123 (19%) 48 (16%) 75 (22%) 0.045
CPB (yes) 295 (46%) 140 (46%) 155 (46%) 0.94

Abbreviations: Coronary Artery Bypass Surgery (CABG), Cardiopulmonary Bypass (CPB), Glycoprotein GIIb/IIIa inhibitor (GIIb/IIIa), Intra Aortic Balloon Pump (IABP), New York Heart Association (NYHA), Percutaneous Cardiac Interventions (PCI)